Company Data
Tempest Therapeutics Inc.
Ticker
TPST
Current Price
$1.45 -5.23%
Market Cap
$21.5M
Price Target
Refer to Report
Volume
189.8K
52wk Range
$1.5 - $12.23
Overview
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity.